Abstract
Four new compounds, phomalichenones A–D (1–4), and seven known compounds (5–11) were isolated from the cultures of an endolichenic fungus Phoma sp. EL002650. Their structures were determined by the analysis of their spectroscopic data (NMR and MS). Compounds 1 and 6 inhibited nitric oxide (NO) production in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages. In addition, compound 1 diminished the protein expression levels of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), and decreased the mRNA expression levels of pro-inflammatory cytokines, such as tumor necrosis factor-α (TNF-α), interleukin(IL)-1β, and IL-6.
Lichens are composite organisms consisting of a fungal organism (mycobiont) and a photosynthesizing organism (photobiont), such as algae or cyanobacteria [1, 2]. Endolichenic fungi are found living with lichen-forming fungi similarly to endophytic fungi living symbiotically with the healthy tissues of plants [2,3,4]. Since metabolites from endolichenic fungi were first reported 10 years ago, research on endolichenic fungal secondary metabolites has increased, and endolichenic fungi have become a proven source of bioactive secondary metabolites [2], including alkaloids [5, 6], quinones [7,8,9,10], peptides [11], chromones [12], and terpenes [13,14,15,16]. These metabolites have shown antiviral, antibacterial, antifungal, and anti-Alzheimer’s disease activities. We investigated new bioactive compounds from the endolichenic fungus Phoma sp. EL002650. The fungal strain Phoma sp. was cultured in potato dextrose broth (PDB, 5 l) for 7 days at 25 °C, and the broth and mycelia extracts were partitioned with EtOAc/H2O. Four new phomalone derivatives phomalichenones A–D (1–4) and seven known (5–11) compounds were separated from the EtOAc extract. Herein, we describe their isolation, structure elucidation, and biological activities.
Compound 1 was obtained as a yellow amorphous powder. The molecular formula of 1 was deduced as C13H16O4 based on the analysis of the HRESIMS and NMR data. The 1H, 13C, and DEPT data in conjunction with the HSQC-DEPT spectrum of 1 suggested the presence of 13 carbons, containing one carbonyl carbon (δC 191.8), five nonprotonated carbons (δC 164.6, 162.9, 160.4, 109.4, and 103.8), three olefinic methine carbons (δC 142.1, 131.7, and 90.9), one methoxy carbon (δC 55.5), one methylene carbon (δC 15.1), and two methyl carbons (δC 18.3, and 13.5). The 1H NMR data of 1 indicated the presence of two coupled olefinic protons (δH 7.23 and 6.94), one singlet olefinic proton (δH 6.06), one methoxy proton (δH 3.79), one methylene proton (δH 2.45), one doublet methyl proton (δH 1.92), and one triplet methyl proton (δH 0.98) (Table 1). The interpretation of the 2D NMR data, including the COSY, HSQC-DEPT, and HMBC spectra, led to the construction of the planar structure of 1 (Fig. 1b). The COSY correlations of H2-1´/H3-2´ and the HMBC correlations of H3-2´ to C-1´ and C-9 and H2-1´ to C-8, C-9, and C-10 indicated the presence of an ethyl side chain that was connected at C-9. Another side chain was established by the COSY correlations of H-2/H-3/H3-4 and the HMBC correlations of H-2 to C-1 and C-4, H-3 to C-1, and H3-4 to C-2. Thus, the planar structure of phomalichenone A (1) was assigned as shown in Fig. 1. The large coupling constants (JH2–H3 = 14.7 Hz) revealed that the H-2 and H-3 double bond had a trans configuration.
Compound 2 was isolated as a white amorphous powder. Its molecular formula was established as C13H18O6 by the HRESIMS and NMR data. The 1H and 13C NMR data of 2 were closely similar to those of phomalone (7) (Supplementary Figures S8 and S35). The different resonance was an oxymethylene at C-4, which was confirmed by the COSY correlation of H2-2/H2-3/H2-4. The hydroxylation of C-4 was supported by the deshielded signals of C-4 (δC 60.4) and H2-4 (δH 3.43). Therefore, the structure of 2 was designated as phomalichenone B (2).
Compound 3 was isolated as a white amorphous powder. The molecular formula of 3 was determined to be C12H12O5 by the HRESIMS and NMR data. The analysis of the 13C NMR and HSQC-DEPT data suggested the presence of 12 carbons, comprising one carbonyl carbon (δC 181.4), six nonprotonated carbons (δC 166.8, 164.4, 158.9, 155.9, 108.6, and 102.4), two olefinic carbons (δC 107.6 and 93.2), two methylene carbons (δC 59.8 and 26.1), and one methyl carbon (δC 19.8). The 1H NMR data indicated two single olefinic protons (δH 6.31 and 6.10), one oxymethylene proton (δH 3.44), one methylene proton (δH 2.71), and one methyl proton (δH 2.32) (Table 1). The HMBC correlations of H-2 to C-4 and C-5 and H-7 to C-5 and C-9 established the chromen-4-one structure. The COSY correlations of H2-1´/H2-2´ and the HMBC correlations of H2-2´ to C-1´ and C-9 and H2-1´ to C-8, C-9, and C-10 indicated the presence of a hydroxyethyl side-chain that was connected at C-9. Thus, the planar structure of 3 was assigned as a new member of the chromone family and designated as phomalichenone C (3).
Compound 4 was obtained as a white amorphous powder. The molecular formula of 4 was deduced as C13H14O4 by the HRESIMS and NMR data. The 1H and 13C NMR spectra of 4 showed similarity to those of 3. The different resonances were a methoxy group of C-6 and a methyl at C-2´, which were supported by the HMBC correlation of 6-OCH3 to C-6 and the COSY correlation of H2-1´/H3-2´ (Fig. 1b). The structure of 4 was similar to that of 3 and designated as phomalichenone D (4).
Compound 5 is known, although the NMR data of 5 was not reported [17]. We report the NMR data of (2,4-dihydroxy-3-(2-hydroxyethyl)-6-methoxyphenyl)-3-hydroxybutan-1-one (5) in this study (Supplementary Figures S29–33).
The other compounds were determined to be (E)-1-(2,4-dihydroxy-3-(2-hydroxyethyl)-6-methoxyphenyl)but-2-en-1-one (6) [18], phomalone (7) [18], deoxyphomalone (8) [18], 8-ethyl-7-hydroxy-5-methoxy-2-methylchroman-4-one (9) [19], LL-D253γ (10) [19], and 4-hydroxy-6-methoxy-5-(1’-oxobutyl) benzodihydrofuran (11) [18] by comparison of our data with that in the published literature.
To evaluate the anti-inflammatory effect of compounds 1–11, we investigated their inhibitory effects on the nitric oxide (NO) production in lipopolysaccharide (LPS)-induced RAW264.7 macrophages. Cytotoxic effects of 1–11 on RAW264.7 cells were evaluated, cell viability was not altered by the exposure to 1–11 at concentrations of 5–40 μm for 24 h; however, cell viability decreased by the exposure to 1 at a concentration of 80 μm for 24 h (Supplementary Figure S40). 1 and 6 significantly inhibited the NO production with IC50 values of 9.4 ± 0.5 and 7.4 ± 2.8 μm, respectively, whereas 2–5 and 7–11 were inactive (Fig. 2a and Supplementary Table S1). This result suggests that the presence of the double bond on the side chain may play an important role for the inhibitory effects of NO production in LPS-stimulated RAW264.7 cells. Under the same conditions, compound 1 decreased PGE2 production in a dose-dependent manner measured by enzyme immunoassay with IC50 values of 12.7 ± 1.5 μm (Fig. 2b). The overproduction of NO and PGE2 is associated with the overexpression of inducible nitric oxide synthesis (iNOS) and cyclooxygenase-2 (COX-2) in LPS-induced RAW264.7 cells. In the Western blot analysis, the protein expression levels of iNOS and COX-2 in RAW264.7 cells were significantly up-regulated in response to LPS, while 1 suppressed iNOS and COX-2 protein expression in LPS-treated cells in a dose-dependent manner (Fig. 2c,d). Pro-inflammatory cytokines, such as tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, and IL-6, have been reported to be important mediators of inflammation [20]. To further examine the anti-inflammatory effect of 1 in LPS-induced RAW264.7 cells, the mRNA expression levels of pro-inflammatory cytokines IL-1β, IL-6, and TNF-α were estimated by RT-qPCR analysis in the cells stimulated with LPS (1 μg ml−1) for 6 h. The transcript levels of IL-1β, IL-6, and TNF-α were decreased in a dose-dependent manner in LPS-treated RAW264.7 cells (Supplementary Figure S41). The nuclear factor-kappa B (NF-κB) is known to play a key role in the expression of pro-inflammatory enzymes and cytokines, such as iNOS, COX-2, TNF-α and interleukines [21]. Therefore, it is proposed that 1 might suppress the activation of NF-κB in LPS-induced RAW264.7 cells.
In summary, phomalichenones A–D (1–4), from endolichenic fungus Phoma sp. EL002650, are new members of the phomalone derivatives and chromone skeleton. In the evaluation of the anti-inflammatory effects of the isolated compounds, compounds 1 and 6 suppressed the production of NO in LPS-stimulated RAW264.7 cells. Especially, compounds 1 and 6 have a double bond on their side chain. Although the structure–activity relationships of phomalone derivatives with a double bond have not been thoroughly investigated, our results suggest that the presence of a double bond on the side chain may be important for the inhibitory effect against NO production. In addition, the anti-inflammatory effect of 1 was confirmed by observing that 1 inhibited the production of PGE2 and suppressed the protein levels of iNOS and COX-2. Also, 1 blocked the mRNA transcription of pro-inflammatory cytokines, such as TNF-α, IL-1β, and IL-6 in LPS-stimulated RAW264.7 cells.
References
Paranagama PA, et al. Heptaketides from Corynespora sp. inhabiting the cavern beard lichen, Usnea cavernosa: first report of metabolites of an endolichenic fungus. J Nat Prod. 2007;70:1700–5.
Kellogg JJ, Raja HA. Endolichenic fungi: a new source of rich bioactive secondary metabolites on the horizon. Phytochem Rev. 2017;16:271–93.
Arnold AE, et al. A phylogenetic estimation of trophic transition networks for ascomycetous fungi: are lichens cradles of symbiotrophic fungal diversification? Syst Biol. 2009;58:283–97.
U’Ren JM, et al. Contributions of north American endophytes to the phylogeny, ecology, and taxonomy of Xylariaceae (Sordariomycetes, Ascomycota). Mol Phylogenet Evol. 2016;98:210–32.
Zheng QC, et al. Chaetoglobosin Y, a new cytochalasan from Chaetominum globosum. Fitoterapia. 2014;93:126–31.
Li XB, et al. Tetramic acids and pyridine alkaloids from endolichenic fungus Tolypocaldium cylindrosporum. J Nat Prod. 2015;78:2155–60.
Chen GD, et al. Xanthoquinodins from the endolichenic fungal strain Chaetomium elatum. J Nat Prod. 2013;76:702–9.
Dou YL, et al. Metabolites from Aspergillus versicolor, an endolichenic fungus from the lichen Lobaria retigera. Drug Discov Ther. 2014;8:84–88.
Ding G, et al. Ambuic acid and torreyanic acid derivatives from the endolichenic fungus Pestalotiopsis sp. J Nat Prod. 2009;72:182–6.
Wijeratne EMK, Bashyal BP, Gunatolaka ML, Arnold AE, Gunatilaka AAL. Maximizing chemical diversity of fungal metabolites: biogenetically related heptaketides of the endolichenic fungus Corynespora sp. J Nat Prod. 2010;73:1156–9.
Wu W, et al. Isolation and structural elucidation of proline-containing cyclopentapeptides from an endolichenic Xylaria sp. J Nat Prod. 2011;74:1303–8.
Zhang F, Li L, Si Y, Guo L, Jiang X, Che Y. A thiopyranchromenone and other chromone derivatives from an endolichenic fungus. Preuss Afr J Nat Prod. 2012;75:230–7.
Wijeratne EMK, et al. Geopyxins A–E, ent-kaurane diterpenoids from endolichenic fungal strains Geopyxis aff. majalis and Geopyxis sp. AZ0066: structure–activity relationships of geopyxins and their analogues. J Nat Prod. 2012;75:361–9.
Wang QX, et al. Tricycloalternarenes F–H: three new mixed terpenoids produced by an endolichenic fungus Ulocladium sp. using OSMAC method. Fitoterapia. 2013;85:8–13.
Wu YH, et al. Pericoterpenoid A, a new bioactive cadinane-type sesquiterpene from Periconia sp. J Asian Nat Prod Res. 2015;17:671–5.
Li XB, et al. Identification and biological evaluation of secondary metabolites from the endolichenic fungus Aspergillus versicolor. Chem Biodivers. 2015;12:575–92.
Ayer WA, Hiratsuka Y, Trifonov LS, Chakravarty, P. Agents with antifungal activity and methods of use thereof. PCT WO 97/48279 (1997).
Ayer WA, Jimenez LD. Phomalone, an antifungal metabolite of Phoma etheridgei. Can J Chem. 1994;72:2326–32.
Chandler IM, Mclntyre CR, Simpson TJ. Biosynthesis of LL-D253α, a polyketide chromanone metabolite of Phoma pigmentivora: incorporation of 13C, 2H and 18O labelled precursors. J Chem Soc Perkin Trans. 1992;1:2285–93.
Bendtzen K. Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunity. Immunol Lett. 1988;19:183–91.
Baeuerle PA, Baltimore D. NF-κB: ten years after. Cell. 1996;87:13–20.
Acknowledgements
This work was supported by the International Joint Research Project (ASIA-16-011) of the NST (National Research Council of Science & Technology), Young Researcher Program (NRF-2017R1C1B2002602) of the NRF (National Research Foundation of Korea), and KRIBB Research Initiative Program funded by the Ministry of Science ICT (MSIT) of Republic of Korea. We thank the Korea Basic Science Institute, Ochang Korea, for providing the NMR (700 MHz) and HRESIMS data.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Kim, J.W., Ko, W., Kim, E. et al. Anti-inflammatory phomalichenones from an endolichenic fungus Phoma sp.. J Antibiot 71, 753–756 (2018). https://doi.org/10.1038/s41429-018-0058-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41429-018-0058-7
This article is cited by
-
Four new chromone derivatives from the Arctic fungus Phoma muscivora CPCC 401424 and their antiviral activities
The Journal of Antibiotics (2023)
-
Promising antimicrobials from Phoma spp.: progress and prospects
AMB Express (2022)